EMERALD ADVISERS, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001015083
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q1 2025 · 243 positions · Total reported value $2.22B · Top-10 concentration 20.2% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 51.0% · 14 new · 86 cut · 28 exited
Active Share (vs S&P 500): 97.9% · vs QQQ: 98.3% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -14.5% · vs SPY -16.6% · Prev Value $4.25B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -4.4% · vs SPY -6.6% · Latest Value $3.63B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q1 2025 13F filing, EMERALD ADVISERS, LLC disclosed 243 equity positions with a combined reported value of $2.22B. The filing implies a diversified portfolio: its ten largest positions account for 20.2% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.
The largest disclosed positions as of Q1 2025 were FTAI ($52.91M), PLMR ($51.64M), CRDO ($49.36M). By sector, the heaviest allocations are Health Care 21.5%, Technology 19.0%. Versus the prior quarter, allocation shifted toward Financials (+2.8pp), Health Care (+1.8pp) and away from Communication Services (-0.5pp), Other (-0.9pp).
Versus the prior quarter, EMERALD ADVISERS, LLC opened 14 new positions, trimmed 86 and fully exited 28, a turnover rate of 51.0% of positions. The portfolio's overlap with the prior quarter was 81% of names.
The largest new positions opened in Q1 2025 were GH ($22.64M), LTH ($19.92M), VSEC ($19.67M).
Of the 28 positions fully exited versus the prior quarter, the largest were ITCI ($36.59M), NVEE ($13.24M), FLYW ($8.88M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q1 2025)
Fully Exited (vs previous quarter)
- ITCI INTRA CELLULAR THERAPIES INC · prev qtr: $36.59M
- NVEE NV5 GLOBAL INC · prev qtr: $13.24M
- FLYW FLYWIRE CORPORATION · prev qtr: $8.88M
- SIGI SELECTIVE INS GROUP INC · prev qtr: $7.64M
- WGS GENEDX HOLDINGS CORP · prev qtr: $7.06M
- KROS KEROS THERAPEUTICS INC · prev qtr: $3.87M
- TNET TRINET GROUP INC · prev qtr: $3.70M
- ATRC ATRICURE INC · prev qtr: $2.72M
Insider Transactions (Form 4)
Latest EMERALD ADVISERS, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Emerald Advisers is an SEC-registered 13F filer based in Leola, PA, United States. As of Q2 2026 it reported 237 US equity positions with a combined value of $4.25B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: LEOLA, PA, United States
- SEC registration: 801-40263 (status: Approved), registered 1991-11-25
- Regulatory AUM (Form ADV): $3.30B as of 2026-03-31
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Website: teamemerald.com
Portfolio Structure
- 237 positions · $4.25B reported value (Q2 2026)
- Top 10 holdings = 17.4% of reported value
- Largest position: TVTX (TRAVERE THERAPEUTICS INC) at 2.1%
- Average position size: $17.93M
Sector Tilt
- Information Technology 26.5%
- Health Care 21.7%
- Consumer Discretionary 19.5%
- (classified holdings cover 99% of value)
Quarterly Activity
- Q2 2026: 28 new, 76 added, 81 reduced, 39 exited
- 52 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
476.58K | $52.91M | 2.38% | Reduce | |
| 2 |
|
376.70K | $51.64M | 2.33% | Reduce | |
| 3 |
|
1.23M | $49.36M | 2.22% | Reduce | |
| 4 |
|
594.01K | $45.32M | 2.04% | Reduce | |
| 5 |
|
1.48M | $43.88M | 1.98% | Reduce | |
| 6 |
|
814.88K | $43.12M | 1.94% | Reduce | |
| 7 |
|
509.45K | $42.37M | 1.91% | Add | |
| 8 |
|
564.48K | $40.33M | 1.82% | Reduce | |
| 9 |
|
1.15M | $39.60M | 1.78% | Hold | |
| 10 |
|
493.43K | $39.48M | 1.78% | Add | |
| 11 |
|
2.08M | $37.22M | 1.68% | Reduce | |
| 12 |
|
907.07K | $36.69M | 1.65% | Reduce | |
| 13 |
|
198.40K | $35.95M | 1.62% | Reduce | |
| 14 |
|
401.64K | $35.55M | 1.60% | Reduce | |
| 15 |
|
246.04K | $35.52M | 1.60% | Reduce | |
| 16 |
|
533.59K | $34.43M | 1.55% | Add | |
| 17 |
|
744.62K | $33.28M | 1.50% | Reduce | |
| 18 |
|
279.81K | $32.56M | 1.47% | Add | |
| 19 |
|
645.22K | $32.08M | 1.44% | Reduce | |
| 20 |
|
151.10K | $31.24M | 1.41% | Reduce | |
| 21 |
|
454.79K | $30.60M | 1.38% | Add | |
| 22 |
|
587.25K | $30.55M | 1.38% | Reduce | |
| 23 |
|
978.20K | $29.81M | 1.34% | Add | |
| 24 |
|
280.68K | $29.67M | 1.34% | Reduce | |
| 25 |
|
1.44M | $29.53M | 1.33% | Add | |
| 26 |
|
746.51K | $29.32M | 1.32% | Reduce | |
| 27 |
|
548.27K | $28.97M | 1.30% | Add | |
| 28 |
|
510.81K | $28.60M | 1.29% | Add | |
| 29 |
|
139.49K | $27.55M | 1.24% | Add | |
| 30 |
|
530.70K | $27.48M | 1.24% | Reduce | |
| 31 |
|
224.82K | $26.80M | 1.21% | Add | |
| 32 |
|
424.09K | $26.44M | 1.19% | Hold | |
| 33 |
|
3.13M | $25.32M | 1.14% | Reduce | |
| 34 |
|
426.47K | $24.89M | 1.12% | Hold | |
| 35 |
|
826.48K | $24.67M | 1.11% | Add | |
| 36 |
|
531.42K | $22.64M | 1.02% | New | |
| 37 |
|
237.18K | $21.82M | 0.98% | Reduce | |
| 38 |
|
265.42K | $21.69M | 0.98% | Reduce | |
| 39 |
|
612.04K | $21.41M | 0.96% | Reduce | |
| 40 |
|
261.29K | $20.05M | 0.90% | Hold | |
| 41 |
|
659.52K | $19.92M | 0.90% | New | |
| 42 |
|
578.33K | $19.81M | 0.89% | Reduce | |
| 43 |
|
163.94K | $19.67M | 0.89% | New | |
| 44 |
|
378.56K | $19.03M | 0.86% | Add | |
| 45 |
|
516.23K | $18.69M | 0.84% | Hold | |
| 46 |
|
924.78K | $17.67M | 0.80% | Hold | |
| 47 |
|
115.43K | $17.65M | 0.79% | Add | |
| 48 |
|
174.65K | $17.53M | 0.79% | Reduce | |
| 49 |
|
1.34M | $17.17M | 0.77% | Add | |
| 50 |
|
233.49K | $16.94M | 0.76% | Hold | |
FAQ
What did EMERALD ADVISERS, LLC buy in 2025-Q1?
In its 2025-Q1 13F filing, EMERALD ADVISERS, LLC reported 243 equity positions worth $2.22B in aggregate; its largest disclosed positions were FTAI ($52.91M), PLMR ($51.64M), CRDO ($49.36M).
How large is EMERALD ADVISERS, LLC's portfolio?
EMERALD ADVISERS, LLC reported $2.22B of long equity holdings across 243 positions as of 2025-Q1. Top-10 holdings account for 20.2% of reported value.
What is EMERALD ADVISERS, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.